Literature DB >> 6600795

Bleeding manifestations in 100 patients with amyloidosis.

R A Yood, M Skinner, A Rubinow, L Talarico, A S Cohen.   

Abstract

Focal or generalized hemorrhage is a commonly encountered clinical problem in patients with amyloidosis. In 100 patients with amyloidosis, 41 patients experienced one or more bleeding episodes: petechiae and ecchymoses (23), gastrointestinal tract bleeding (18), bleeding after a diagnostic procedure (eight), hematuria (three), hemoptysis (two), and miscellaneous (four). Severe hemorrhage was the cause of death in three patients. Bleeding occurred frequently in the absence of abnormalities of clotting tests, suggesting that hemorrhage in amyloidosis is most often due to amyloid infiltration of blood vessels. In this group of patients, an isolated factor X deficiency was not observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600795

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

1.  Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review.

Authors:  Martin Tam; David C Seldin; Benjamin M Forbes; Lawreen H Connors; Martha Skinner; Betul Oran; Karen Quillen; Vaishali Sanchorawala
Journal:  Amyloid       Date:  2009       Impact factor: 7.141

Review 2.  Reactive amyloidosis.

Authors:  J David; P Woo
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

3.  A man with new onset of ascites and edema.

Authors:  Melvin Lau
Journal:  Medscape J Med       Date:  2008-04-09

4.  Bleeding manifestations in a patient with amyloidosis.

Authors:  Luai Alhazmi; Abdulelah Nuqali; Ragheb Assaly
Journal:  BMJ Case Rep       Date:  2016-10-08

5.  Hemorrhage because of amyloid-related factor X deficiency after insertion of Tenckhoff catheter.

Authors:  G Harman; B B McCormick
Journal:  Perit Dial Int       Date:  2012 Sep-Oct       Impact factor: 1.756

Review 6.  Amyloidosis in the rheumatic diseases.

Authors:  V Dhillon; P Woo; D Isenberg
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

7.  Upper limb venous thrombosis complicating amyloidosis.

Authors:  W Dickey; M E Callender; E E Mayne
Journal:  Ir J Med Sci       Date:  1986-12       Impact factor: 1.568

Review 8.  Behçet's disease associated with amyloidosis.

Authors:  M Chiba; Y Inoue; H Arakawa; O Masamune; M Ohkubo
Journal:  Gastroenterol Jpn       Date:  1987-08

Review 9.  The 2017 Doyne Lecture: the orbit as a window to systemic disease.

Authors:  A A McNab
Journal:  Eye (Lond)       Date:  2017-11-10       Impact factor: 3.775

Review 10.  Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Authors:  Adam Castaño; Brian M Drachman; Daniel Judge; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.